Fluorine-18 fluorodeoxyglucose imaging using dual-head coincidence positron emission tomography without attenuation correction in patients with head and neck cancer

Clinical Nuclear Medicine

Volumn 24, Issue 7, 1999, Pages 495-500

  Pai, Moonsun ^a   Park, Chan H ^a   Suh, Jung Ho ^a   Koh, Joong Hwa ^a  

^a Ajou University Medical Center   (South Korea)

Author keywords

Coincidence PET; F 18 FDG; Head and neck cancer

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CLINICAL ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; LYMPH NODE METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; GAMMA CAMERAS; HEAD; HEAD AND NECK NEOPLASMS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NECK; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033049805     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-199907000-00004     Document Type: Article

References (19)

1. Lee WJ, Shim YS, Oh KK, Lee YS, Park CK: Nasopharyngeal carcinoma: A clinical study and analysis of prognostic factors. Korean J Otolaryngol 39:1455, 1996.
2. Haberkorn U, Strauss LG, Dimitrakouplilou A, Seihert E, Oberdorfer F: Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med 43:12, 1993.
3. Zeitouni AG, Yamamoto YL, Black M, Gjedde A: Functional imaging of head and neck tumors using positron emission tomography. J Otolaryngol 23:77, 1994.
4. Greven KM, Williams DW, Keys JW, et al: Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 74:1355, 1994.
5. Reisser C, Dimitrkopoulou-Strauss A, Seifert E, Strauss LG: Chemotherapeutic management of head and neck malignancies with positron emission tomography. Arch Otolaryngol Head Neck Surg 121:272, 1995.
6. Minn H, Joensuu H, Ahonen A, Klempi P: FDG Imaging: A method to assess the proliferative activity of human cancer in vivo. Cancer 61:1776, 1988.
7. Wahl RL, Hutchins GD, Buchsbaum DJ, et al: Fluorine-18-2-fluoro-2-deoxy-D-glucose uptake into human tumor xenografts: Feasibility studies for cancer imaging with PET. Cancer 67: 1544, 1991.
8. Anazi Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery and irradiation: Prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. Radiology 200:135, 1996.
9. Bailet JW, Abemayor E, Jabour BA, et al: PET: A new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 102:281, 1992.
10. McGuirt WF, Greven KM, Keys JW, et al: PET in the evaluation of laryngeal carcinoma. Ann Otol Rhinol Laryngol 104:274, 1995.
11. Braams JW, Pruim J, Freling NJM, et al: Detection of lymph node metastases of squamous cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 36:211, 1995.
12. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al: Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous cell carcinomas. J Nucl Med 36:1747, 1995.
13. Steinkamp HJ, Heim T, Zwicker C, et al: The value of nuclear magnetic resonance tomography in tumor staging of laryngeal/hypopharyngeal cancer. HNO 40:339, 1992.
14. Barrington SF, Maisey MN: Skeletal muscle uptake of fluorine-18-FDG: Effect of oral diazepam. J Nucl Med 37:1127, 1996.
15. Mukherji SK, Drane WE, Mancuso AA, et al: Occult primary tumors of the head and neck: Detection with 2-[F-18]fluoro-2-deoxy-D-glucose SPECT. Radiology 199:761, 1996.
16. Leskinen-Kallio S, Nagren K, Lehikohinen P, et al: Carbon-11-methionine and PET is an effective method to image head and neck cancer. J Nucl Med 33:691, 1992.
17. Braams JW, Pruim J, Nikkels PGJ, et al: Nodal spread of squamous cell carcinoma of the oral cavity detected with PET-tyrosine, MRI and CT. J Nucl Med 37:897, 1996.
18. Lapela M, Grenman R, Kurki T, et al: Head and neck cancer: Detection of recurrence with PET and 2-[F-18] fluoro-2-deoxy-D-glucose. Radiology 197:205, 1995.
19. Shreve PD, Steventon RS, Deters EC, et al: Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: Dual-head coincidence gamma camera versus positron emission tomographic scanner. Radiology 207:431, 1998.